Showing results (141-150 of 184) with videos related to
Sort By:
Pageof 19
Annals of Clinical and Translational Neurology|August 23, 2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravisJae-Yun Lee, Panos Stathopoulos, Sasha Gupta, et al.Arthritis and Rheumatism|November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trialChester V Oddis, Ann M Reed, Rohit Aggarwal, et al.Journal of the Peripheral Nervous System : JPNS|January 5, 2011
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practiceKenneth C Gorson, Ivo N van Schaik, Ingemar S J Merkies, et al.Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.Muscle & Nerve|November 3, 2009
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experienceMamatha Pasnoor, Gil I Wolfe, Sharon Nations, et al.Muscle & Nerve|September 19, 2012
A quantitative measure of handgrip myotonia in non-dystrophic myotoniaJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.Muscle & Nerve|September 8, 2018
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialJeffrey M Statland, Dan Moore, Yunxia Wang, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 12, 2020
Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosisHiroshi Mitsumoto, Diana C Garofalo, Regina M Santella, et al.Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.Brain : a Journal of Neurology|August 23, 2015
Closing the tau loop: the missing tau mutationAllan McCarthy, Roisin Lonergan, Diana A Olszewska, et al.Pageof 19